Bright Minds Biosciences Stock Net Asset
| DRUG Stock | USD 1.02 0.03 3.03% |
Bright Minds Biosciences fundamentals help investors to digest information that contributes to Bright Minds' financial success or failures. It also enables traders to predict the movement of Bright Stock. The fundamental analysis module provides a way to measure Bright Minds' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bright Minds stock.
Bright | Net Asset |
Bright Minds Biosciences Company Net Asset Analysis
Bright Minds' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Bright Minds Net Asset | 6.88 M |
Most of Bright Minds' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bright Minds Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Bright Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Bright Minds is extremely important. It helps to project a fair market value of Bright Stock properly, considering its historical fundamentals such as Net Asset. Since Bright Minds' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bright Minds' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bright Minds' interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Bright Total Assets
Total Assets |
|
Based on the recorded statements, Bright Minds Biosciences has a Net Asset of 6.88 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Bright Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bright Minds' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bright Minds could also be used in its relative valuation, which is a method of valuing Bright Minds by comparing valuation metrics of similar companies.Bright Minds is currently under evaluation in net asset category among related companies.
Bright Minds Current Valuation Drivers
We derive many important indicators used in calculating different scores of Bright Minds from analyzing Bright Minds' financial statements. These drivers represent accounts that assess Bright Minds' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Bright Minds' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 45.9M | 81.0M | 20.8M | 8.1M | 9.4M | 8.9M | |
| Enterprise Value | 45.1M | 61.3M | 9.3M | 1.5M | 1.7M | 1.6M |
Bright Minds Institutional Holders
Institutional Holdings refers to the ownership stake in Bright Minds that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bright Minds' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bright Minds' value.| Shares | Advisorshares Investments, Llc | 2023-12-31 | 188.1 K | Hrt Financial Llc | 2023-12-31 | 16.8 K | Renaissance Technologies Corp | 2023-12-31 | 12 K | Virtu Financial Llc | 2023-12-31 | 10.4 K | Ubs Group Ag | 2023-12-31 | 622 | Royal Bank Of Canada | 2023-12-31 | 278 | Aspire Private Capital, Llc | 2024-03-31 | 100.0 | Blackrock Inc | 2023-12-31 | 1.0 |
Bright Fundamentals
| Return On Equity | -0.79 | ||||
| Return On Asset | -0.45 | ||||
| Current Valuation | (2.29 M) | ||||
| Shares Outstanding | 4.46 M | ||||
| Shares Owned By Insiders | 35.71 % | ||||
| Shares Owned By Institutions | 5.15 % | ||||
| Number Of Shares Shorted | 75.7 K | ||||
| Price To Book | 1.29 X | ||||
| EBITDA | (7.33 M) | ||||
| Net Income | (7.37 M) | ||||
| Cash And Equivalents | 8.64 M | ||||
| Cash Per Share | 0.71 X | ||||
| Total Debt | 73.55 K | ||||
| Current Ratio | 22.88 X | ||||
| Book Value Per Share | 1.35 X | ||||
| Cash Flow From Operations | (7.02 M) | ||||
| Short Ratio | 3.12 X | ||||
| Earnings Per Share | (1.29) X | ||||
| Target Price | 4.87 | ||||
| Beta | 1.53 | ||||
| Market Capitalization | 4.47 M | ||||
| Total Asset | 6.88 M | ||||
| Retained Earnings | (31.55 M) | ||||
| Working Capital | 6.53 M | ||||
| Net Asset | 6.88 M |
About Bright Minds Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bright Minds Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bright Minds using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bright Minds Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Bright Minds
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bright Minds position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bright Minds will appreciate offsetting losses from the drop in the long position's value.Moving together with Bright Stock
| 0.68 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.62 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against Bright Stock
| 0.78 | SNDL | SNDL Inc Financial Report 20th of May 2024 | PairCorr |
| 0.72 | CGC | Canopy Growth Corp Downward Rally | PairCorr |
| 0.69 | QLI | Qilian International | PairCorr |
| 0.68 | IMCC | Im Cannabis Corp | PairCorr |
| 0.63 | PAHC | Phibro Animal Health Fiscal Year End 4th of September 2024 | PairCorr |
The ability to find closely correlated positions to Bright Minds could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bright Minds when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bright Minds - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bright Minds Biosciences to buy it.
The correlation of Bright Minds is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bright Minds moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bright Minds Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bright Minds can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Bright Minds Piotroski F Score and Bright Minds Altman Z Score analysis. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Bright Stock analysis
When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Bright Minds' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.29) | Return On Assets (0.45) | Return On Equity (0.79) |
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.